Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Rebecca Moore

Dr Rebecca Moore

Cognitive Assessment Tools – A Practical Guide: Which Option for Whom

Dr David Lim & Prof Richard Harvey

Dr David Lim & Prof Richard Harvey

Fireside Discussion – Chronic Sinusitis & Nasal Polys Management Update

A/Prof Michelle Rodrigues

A/Prof Michelle Rodrigues

Acne Scarring

Dr Mitchell Creinin MD

Dr Mitchell Creinin MD

Natural Estrogen, Contraception and Clot Risk

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024